Tilray Inc (NASDAQ:TLRY – Free Report) – Stock analysts at Roth Capital decreased their Q1 2025 earnings per share estimates for shares of Tilray in a research note issued to investors on Tuesday, October 8th. Roth Capital analyst W. Kirk now expects that the company will post earnings per share of ($0.10) for the quarter, down from their prior forecast of ($0.09). The consensus estimate for Tilray’s current full-year earnings is ($0.16) per share. Roth Capital also issued estimates for Tilray’s FY2025 earnings at ($0.34) EPS.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.04). The business had revenue of $200.00 million during the quarter, compared to analyst estimates of $218.70 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The company’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.10) earnings per share.
Check Out Our Latest Research Report on Tilray
Tilray Price Performance
Shares of TLRY stock opened at $1.63 on Friday. Tilray has a twelve month low of $1.45 and a twelve month high of $2.97. The company has a market capitalization of $1.37 billion, a PE ratio of -4.94 and a beta of 2.13. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The firm has a fifty day simple moving average of $1.75 and a 200-day simple moving average of $1.86.
Institutional Investors Weigh In On Tilray
Large investors have recently added to or reduced their stakes in the stock. Tidal Investments LLC increased its stake in shares of Tilray by 36,687.0% in the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock valued at $26,373,000 after purchasing an additional 10,648,403 shares during the period. Vanguard Group Inc. increased its position in Tilray by 3.5% in the 1st quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock valued at $8,707,000 after acquiring an additional 117,891 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its stake in Tilray by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock valued at $6,699,000 after acquiring an additional 213,834 shares in the last quarter. Bank of Montreal Can boosted its position in Tilray by 19.6% during the 2nd quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after acquiring an additional 355,778 shares during the period. Finally, Swiss National Bank boosted its position in Tilray by 3.6% during the 1st quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock worth $3,683,000 after acquiring an additional 51,700 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
- Five stocks we like better than Tilray
- What Are Trending Stocks? Trending Stocks Explained
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- What is Short Interest? How to Use It
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Using the MarketBeat Stock Split Calculator
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.